Boniva vs. Evista

• Are Boniva and Evista the Same Thing?
• What Are Possible Side Effects of Boniva?
• What Are Possible Side Effects of Evista?
• What is Boniva?
• What is Evista?
• What Drugs Interact with Boniva?
• What Drugs Interact with Evista?
• How Should Boniva Be Taken?
• How Should Evista Be Taken?

Boniva (ibandronate) and Evista (raloxifene hydrochloride) are used to treat or prevent osteoporosis in women after menopause.

Evista is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer.

Boniva is a bisphosphonate and Evista is an estrogen agonist/antagonist.

Common side effects of Boniva include:

• back pain,
• headache,
• redness or swelling of your eyes,
• diarrhea,
• flu-like symptoms,
• nausea or stomach upset,
• pain in your arms or legs,
• redness or swelling where Boniva was injected,
• weakness,
• allergic reaction,
• indigestion,
• vomiting,
• joint pain,
• dizziness,
• spinning sensation (vertigo),
• upper respiratory infection,
• pneumonia, or
• urinary tract infection.

Common side effects of Evista include:

• hot flashes,
• increased sweating,
• headache,
• dizziness,
• spinning sensation,
• leg cramps or leg pain,
• joint pain,
• nausea,
• vomiting,
• stomach pain, or
• runny or stuffy nose.
• Evista may infrequently cause stroke or serious blood clots to form in the legs, lungs, or eyes.

Seek medical attention if you have unlikely but serious side effects of Evista including:

• leg swelling or pain,
• trouble breathing,
• chest pain,
• sudden vision changes,
• severe headache,
• weakness on one side of the body, or
• confusion.

Boniva (ibandronate) is a bisphosphonate drug that alters the cycle of bone formation and breakdown in the body used to treat or prevent osteoporosis in women after menopause. Boniva slows bone loss while increasing bone mass, which may prevent bone fractures.

Evista (raloxifene hydrochloride) is an estrogen agonist/antagonist used to treat or prevent osteoporosis in postmenopausal women. Evista is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer.

Boniva may interact with aspirin or other NSAIDs (non-steroidal anti-inflammatory drugs).

Boniva may also interact with products containing calcium, aluminum, magnesium, or iron (such as antacids, supplements or vitamins).

Evista may interact with cholestyramine, blood thinners, diazepam, diazoxide, birth control pills or hormone replacement therapy.

Dosage of Boniva depends on the condition being treated.

The recommended dosage is one 60 mg Evista tablet daily, taken any time of day without regard to meals.